Endocardial-Epicardial Catheter Ablation Versus Endocardial Catheter Ablation Alone for Ventricular Arrhythmia in Patients With Structural Heart Disease (Meta-Analysis of Reconstructed Time-to-Event Data).

[1]  F. Fernández‐Avilés,et al.  Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia. , 2022, Journal of the American College of Cardiology.

[2]  J. Lee,et al.  IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves , 2020, BMC Medical Research Methodology.

[3]  A. Natale,et al.  Endo‐epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta‐analysis , 2020, Journal of cardiovascular electrophysiology.

[4]  A. d'Avila,et al.  Percutaneous Epicardial Approach to Catheter Ablation of Cardiac Arrhythmias. , 2020, JACC. Clinical electrophysiology.

[5]  A. d'Avila,et al.  Endo‐epicardial vs endocardial‐only catheter ablation of ventricular tachycardia: A meta‐analysis , 2019, Journal of cardiovascular electrophysiology.

[6]  P. Lambiase,et al.  Ablation compared with drug therapy for recurrent ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: Results from a multicenter study. , 2019, Heart rhythm.

[7]  K. Kuck,et al.  Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach , 2019, Journal of the American Heart Association.

[8]  P. Royston,et al.  Reconstructing Time-to-event Data from Published Kaplan–Meier Curves , 2017 .

[9]  G. Hindricks,et al.  Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation? , 2017, Journal of Interventional Cardiac Electrophysiology.

[10]  H. Deng,et al.  Long-Term Outcomes of Radio-Frequency Catheter Ablation on Ventricular Tachycardias Due to Arrhythmogenic Right Ventricular Cardiomyopathy: A Single Center Experience , 2017, PloS one.

[11]  M. Hernán,et al.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.

[12]  D. Packer,et al.  Outcomes of Combined Endocardial-Epicardial Ablation Compared With Endocardial Ablation Alone in Patients Who Undergo Epicardial Access. , 2016, The American journal of cardiology.

[13]  F. Marchlinski,et al.  Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials. , 2016, Heart rhythm.

[14]  John L Sapp,et al.  Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. , 2016, The New England journal of medicine.

[15]  R. Ruiz-Granell,et al.  Endo-Epicardial Versus Only-Endocardial Ablation as a First Line Strategy for the Treatment of Ventricular Tachycardia in Patients With Ischemic Heart Disease , 2015, Circulation. Arrhythmia and electrophysiology.

[16]  Kalyanam Shivkumar,et al.  Our Approach to Minimize Risk of Epicardial Access: Standard Techniques with the Addition of Electroanatomic Mapping Guidance , 2013, Journal of cardiovascular electrophysiology.

[17]  R. Mandapati,et al.  Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy. , 2013, Heart rhythm.

[18]  Sanghamitra Mohanty,et al.  Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. , 2012, Journal of the American College of Cardiology.

[19]  S. Russell,et al.  Outcomes of Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2012, Circulation. Arrhythmia and electrophysiology.

[20]  Nicky J Welton,et al.  Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves , 2012, BMC Medical Research Methodology.

[21]  A. Verma,et al.  Ablation of Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Arrhythmia-Free Survival After Endo-Epicardial Substrate Based Mapping and Ablation , 2011, Circulation. Arrhythmia and electrophysiology.

[22]  V. Aiello,et al.  Percutaneous Transatrial Access to the Pericardial Space for Epicardial Mapping and Ablation , 2011, Circulation. Arrhythmia and electrophysiology.

[23]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[24]  D. Mark,et al.  Prognostic importance of defibrillator shocks in patients with heart failure. , 2008, The New England journal of medicine.

[25]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[26]  J. Brugada,et al.  Infarct transmurality as a criterion for first-line endo-epicardial substrate-guided ventricular tachycardia ablation in ischemic cardiomyopathy. , 2016, Heart rhythm.